NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email OTTAWA — Amid the many layers of tariffs and exemptions from the United States, some economists say the effective tariff rate on Canada is much lower than the headline figures suggest.Read More